Brian Wright
Stock Analyst at Roth MKM
(0.46)
# 4,182
Out of 5,090 analysts
31
Total ratings
27.59%
Success rate
-21.99%
Average return
Main Sectors:
Stocks Rated by Brian Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIOX Bioceres Crop Solutions | Maintains: Buy | $20 → $21 | $1.50 | +1,300.00% | 5 | Feb 9, 2024 | |
| ANDE The Andersons | Reiterates: Buy | $65 | $50.01 | +29.97% | 3 | Feb 6, 2024 | |
| BG Bunge Global | Maintains: Buy | $161 → $138 | $93.63 | +47.39% | 2 | Feb 5, 2024 | |
| ADM Archer-Daniels-Midland Company | Downgrades: Neutral | $98 → $66 | $59.01 | +11.85% | 2 | Jan 22, 2024 | |
| FMC FMC Corporation | Initiates: Buy | $74 | $13.28 | +457.23% | 1 | Jan 4, 2024 | |
| CTVA Corteva | Maintains: Buy | $82 → $63 | $66.00 | -4.55% | 2 | Nov 22, 2023 | |
| LNN Lindsay | Upgrades: Buy | $128 → $150 | $118.88 | +26.18% | 3 | Oct 23, 2023 | |
| PAHC Phibro Animal Health | Reiterates: Buy | $21 | $39.16 | -46.37% | 3 | Sep 1, 2023 | |
| UGRO urban-gro | Reiterates: Buy | $11 | $0.23 | +4,786.72% | 2 | Sep 1, 2023 | |
| XXII 22nd Century Group | Reiterates: Buy | $248,400 | $1.06 | +23,433,862.26% | 2 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $60 | $1.11 | +5,305.41% | 3 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $39 | $2.53 | +1,441.50% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $297 | $414.89 | -28.41% | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $0.99 | +11,984.59% | 1 | Oct 8, 2021 |
Bioceres Crop Solutions
Feb 9, 2024
Maintains: Buy
Price Target: $20 → $21
Current: $1.50
Upside: +1,300.00%
The Andersons
Feb 6, 2024
Reiterates: Buy
Price Target: $65
Current: $50.01
Upside: +29.97%
Bunge Global
Feb 5, 2024
Maintains: Buy
Price Target: $161 → $138
Current: $93.63
Upside: +47.39%
Archer-Daniels-Midland Company
Jan 22, 2024
Downgrades: Neutral
Price Target: $98 → $66
Current: $59.01
Upside: +11.85%
FMC Corporation
Jan 4, 2024
Initiates: Buy
Price Target: $74
Current: $13.28
Upside: +457.23%
Corteva
Nov 22, 2023
Maintains: Buy
Price Target: $82 → $63
Current: $66.00
Upside: -4.55%
Lindsay
Oct 23, 2023
Upgrades: Buy
Price Target: $128 → $150
Current: $118.88
Upside: +26.18%
Phibro Animal Health
Sep 1, 2023
Reiterates: Buy
Price Target: $21
Current: $39.16
Upside: -46.37%
urban-gro
Sep 1, 2023
Reiterates: Buy
Price Target: $11
Current: $0.23
Upside: +4,786.72%
22nd Century Group
Aug 23, 2023
Reiterates: Buy
Price Target: $248,400
Current: $1.06
Upside: +23,433,862.26%
Jul 21, 2023
Maintains: Buy
Price Target: $10 → $60
Current: $1.11
Upside: +5,305.41%
Apr 3, 2023
Maintains: Buy
Price Target: $78 → $39
Current: $2.53
Upside: +1,441.50%
Jun 3, 2022
Initiates: Buy
Price Target: $297
Current: $414.89
Upside: -28.41%
Oct 8, 2021
Initiates: Buy
Price Target: $120
Current: $0.99
Upside: +11,984.59%